Our Mission

To make prescription drugs more affordable for all Americans. CSRxP advocates for bipartisan solutions that hold pharmaceutical companies accountable for out-of-control drug prices and provide more affordable choices for patients. We believe in market-based reforms that address the underlying causes of high drug prices in the U.S. through increased transparency, competition, and value.

Learn More

Second Opinion: No, Big Pharma Is Not Changing

Right on cue, dozens of pharmaceutical companies rang in the new year by increasing hundreds of drug prices by up to 15 times the rate of inflation – despite the fact that their profits continue

01-11-2019 Read More

With 116th Congress Commencing, CSRxP Announces New Website Launch To Help Lawmakers Address Drug Pricing Crisis

With ‘taking action to lower drug prices’ becoming Americans’ top priority for the 116th Congress, the Campaign for Sustainable Rx Pricing (CSRxP) launched a new website to help members and

01-8-2019 Read More

SHOT/CHASER: Analysts Suggest Drug Makers Are Changing Their Ways; Drug Makers Increase Prices By Up To 15 Times Rate Of Inflation

For Immediate Release Contact: Lauren Blair (201) 213-5004 [email protected]om SHOT: Analysts Suggest Drug Makers Are Changing Their Ways: Analyst Says Industry Appears To Be “Self-Policing.

01-4-2019 Read More

View All

The Crisis

Drug prices are out-of-control. At a time when one-in-four Americans cannot afford their medication, Big Pharma is posting record profits – doubling down on monopolistic tactics to game America’s patent system, prevent generic and biosimilar competition and patient choice and pad their bottom lines.

No patient should ever have to choose between paying for their daily needs or taking the medicine they need to live. Every person deserves access to the medications they need at a price they can afford, especially those who can least afford them.

 

Learn More

Solutions

Americans deserve choice and control over their health. We must all work together to promote competition and increase access to high-quality, affordable treatments and cures for patients. It’s time for real solutions that can deliver more choices, more competition, and lower drug prices by addressing the root causes of price gouging:

Transparency: Patients deserve open and honest drug pricing – clear information about the true costs of treatment, how the price of medication is set, and how much it actually costs to bring new drugs to market so they can make more informed decisions about their medications, particularly those with high price tags.

Accountability: When Big Pharma is able to prevent competition and maintain a monopoly on medicines, they can set any price they want. It’s time for Congress to step in and hold Big Pharma accountable for out-of-control drug prices, unchecked price gouging, and rampant patent abuse.

Competition: Big Pharma’s ability to raise the price of a drug overnight or allow the prices of old drugs rise to shadow the prices of comparable new drugs, means we are not operating in a healthy, functioning market. The market can work, but right now it is broken. Bringing competition into the prescription drug market will give consumers more choices and more control – resulting in lower prices and greater access.

Value: Patients deserve reliable information regarding whether a drug’s “therapeutic outcome” – or its health benefit – is in line with its price. That information will be critical to moving America’s prescription drug market toward a system that empowers doctors and patients to choose medications based on the value they provide – not a “value” set by drug manufacturers.

Learn More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.

Who we are

The Campaign for Sustainable Rx Pricing (CSRxP) is a broad-based coalition of leaders – physicians, nurses, hospitals, consumers, health plans, PBMs, pharmacists, and businesses – promoting bipartisan, market-based solutions to lower drug prices in America.

Keep the Conversation Going

ICYMI: A by-the-numbers look at #BigPharma’s price gouging tactics, revealing hikes up to 30% on America’s sickest patients → www.bloomberg.com/news/articles/2019-01-15/rising-drug-prices-said-to-strain-hospitals-force-budg... ... See MoreSee Less

4 hours ago